Foresite Capital Management II as of June 30, 2016
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 15 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aimmune Therapeutics | 29.4 | $43M | 4.0M | 10.82 | |
| Universal American | 14.6 | $21M | 2.8M | 7.58 | |
| Aerie Pharmaceuticals | 11.7 | $17M | 975k | 17.60 | |
| Alder Biopharmaceuticals | 10.3 | $15M | 601k | 24.97 | |
| Epizyme | 8.3 | $12M | 1.2M | 10.24 | |
| Nanostring Technologies (NSTGQ) | 6.3 | $9.2M | 728k | 12.60 | |
| Adaptimmune Therapeutics (ADAP) | 5.9 | $8.6M | 1.1M | 8.15 | |
| Zafgen | 3.1 | $4.6M | 760k | 5.99 | |
| Nexvet Biopharma Pub Ltd Co ord | 2.9 | $4.2M | 900k | 4.64 | |
| Ardelyx (ARDX) | 2.6 | $3.7M | 429k | 8.73 | |
| Orexigen Therapeutics | 1.6 | $2.3M | 5.4M | 0.43 | |
| Acceleron Pharma | 1.1 | $1.7M | 49k | 33.99 | |
| Neuroderm Ltd F | 0.9 | $1.4M | 83k | 16.25 | |
| Regenxbio Inc equity us cm (RGNX) | 0.9 | $1.3M | 157k | 8.00 | |
| BioDelivery Sciences International | 0.5 | $791k | 335k | 2.36 |
